| |
| |
|
| Insider
Information: |
Mahoney David L |
| Relationship: |
Director |
| City: |
Cupertino |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
212,270 |
|
|
Indirect Shares
|
1,261,596 |
|
|
| Direct
Value |
$5,014,997 |
|
|
|
Indirect Value
|
$28,767,082 |
|
|
| Total
Shares |
1,473,866 |
|
|
| Total
Value |
$33,782,079 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -28.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Symantec Corp |
SYMC |
Director |
2018-05-17 |
184,464 |
2018-05-17 |
2,835 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
|
2024-04-10 |
27,806 |
2024-04-10 |
1,258,761 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2021-11-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2024-04-10 |
4 |
A |
$0.00 |
$0 |
I/I |
27,806 |
1,212,614 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2024-04-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,806) |
27,806 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2024-04-10 |
4 |
D |
$23.80 |
$52,217 |
D/D |
(2,194) |
27,806 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2024-04-10 |
4 |
OE |
$1.74 |
$52,200 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2023-08-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
52,270 |
1,169,808 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2023-08-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
34,850 |
46,147 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
|
– • – |
2023-08-14 |
4 |
S |
$30.95 |
$773,668 |
I/I |
(25,000) |
1,222,078 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2023-05-08 |
4 |
D |
$23.76 |
$52,201 |
I/I |
(2,197) |
1,237,078 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2023-05-08 |
4 |
OE |
$1.74 |
$52,200 |
I/I |
30,000 |
1,239,275 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2022-05-27 |
4 |
OE |
$4.05 |
$121,500 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2022-05-27 |
4 |
D |
$21.00 |
$121,506 |
D/D |
(5,786) |
24,214 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(112,781) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
115,153 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2021-05-11 |
4/A |
GD |
$0.00 |
$0 |
D/D |
112,500 |
0 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2021-05-11 |
4/A |
GA |
$0.00 |
$0 |
I/I |
112,500 |
1,232,388 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2021-05-11 |
4 |
D |
$20.45 |
$132,598 |
D/D |
(6,484) |
112,500 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2021-05-11 |
4 |
OE |
$4.42 |
$132,600 |
D/D |
30,000 |
118,984 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2021-03-12 |
4 |
OE |
$0.67 |
$31,920 |
D/D |
48,000 |
110,153 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
62,153 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2020-05-22 |
4 |
OE |
$3.47 |
$135,274 |
D/D |
38,984 |
88,984 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • – |
2019-09-17 |
4 |
OE |
$1.76 |
$58,498 |
D/D |
33,332 |
57,153 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2019-06-03 |
4 |
OE |
$0.96 |
$48,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| SYMC |
Symantec Corp |
Director |
– • – |
2018-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
12,320 |
184,464 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Director |
– • – |
2017-11-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,785 |
1,119,888 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
